製品: OMA1 Antibody
カタログ: DF12435
タンパク質の説明: Rabbit polyclonal antibody to OMA1
アプリケーション: WB IHC IF/ICC
Cited expt.: WB
反応性: Human, Mouse, Rat
予測: Zebrafish, Bovine, Sheep, Rabbit
分子量: 60 kDa; 60kD(Calculated).
ユニプロット: Q96E52
RRID: AB_2845240

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Zebrafish(83%), Bovine(83%), Sheep(83%), Rabbit(83%)
クローナリティ:
Polyclonal
特異性:
OMA1 Antibody detects endogenous levels of total OMA1.
RRID:
AB_2845240
引用形式: Affinity Biosciences Cat# DF12435, RRID:AB_2845240.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

2010001O09Rik; DAB1; FLJ33782; Metalloendopeptidase OMA1; Metalloendopeptidase OMA1, mitochondrial; Metalloprotease-related protein 1; mitochondrial; MPRP 1; MPRP-1; MPRP1; OMA1; OMA1 homolog zinc metallopeptidase; OMA1 homolog, zinc metallopeptidase (S. cerevisiae); OMA1 zinc metallopeptidase; OMA1 zinc metallopeptidase homolog; OMA1_HUMAN; Overlapping activity with M-AAA protease; Overlapping with the m-AAA protease 1 homolog; peptidase; YKR087C; Zinc metallopeptidase OMA1; ZMPOMA1;

免疫原

免疫原:

A synthesized peptide derived from human OMA1, corresponding to a region within the internal amino acids.

Uniprot:
遺伝子(ID):
発現特異性:
Q96E52 OMA1_HUMAN:

Widely expressed, with strong expression in the heart, skeletal muscle, kidney and liver.

タンパク質配列:
MSFICGLQSAARNHVFFRFNSLSNWRKCNTLASTSRGCHQVQVNHIVNKYQGLGVNQCDRWSFLPGNFHFYSTFNNKRTGGLSSTKSKEIWRITSKCTVWNDAFSRQLLIKEVTAVPSLSVLHPLSPASIRAIRNFHTSPRFQAAPVPLLLMILKPVQKLFAIIVGRGIRKWWQALPPNKKEVVKENIRKNKWKLFLGLSSFGLLFVVFYFTHLEVSPITGRSKLLLLGKEQFRLLSELEYEAWMEEFKNDMLTEKDARYLAVKEVLCHLIECNKDVPGISQINWVIHVVDSPIINAFVLPNGQMFVFTGFLNSVTDIHQLSFLLGHEIAHAVLGHAAEKAGMVHLLDFLGMIFLTMIWAICPRDSLALLCQWIQSKLQEYMFNRPYSRKLEAEADKIGLLLAAKACADIRASSVFWQQMEFVDSLHGQPKMPEWLSTHPSHGNRVEYLDRLIPQALKIREMCNCPPLSNPDPRLLFKLSTKHFLEESEKEDLNITKKQKMDTLPIQKQEQIPLTYIVEKRTGS

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Bovine
83
Sheep
83
Zebrafish
83
Rabbit
83
Dog
75
Xenopus
70
Pig
67
Chicken
67
Horse
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

Metalloprotease that is part of the quality control system in the inner membrane of mitochondria. Following stress conditions that induce loss of mitochondrial membrane potential, mediates cleavage of OPA1 at S1 position, leading to OPA1 inactivation and negative regulation of mitochondrial fusion. May also cleave UQCC3 under these conditions. Its role in mitochondrial quality control is essential for regulating lipid metabolism as well as to maintain body temperature and energy expenditure under cold-stress conditions.

PTMs:

In normal conditions, cleaved into an inactive 40 kDa form. Following CCCP treatment that induces loss of mitochondrial membrane potential, the 40 kDa form is reduced in favor of an active 60 kDa form.

細胞の位置付け:

Mitochondrion inner membrane>Multi-pass membrane protein.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Widely expressed, with strong expression in the heart, skeletal muscle, kidney and liver.

タンパク質ファミリー:

Belongs to the peptidase M48 family.

参考文献

1). The NLRX1-SLC39A7 complex orchestrates mitochondrial dynamics and mitophagy to rejuvenate intervertebral disc by modulating mitochondrial Zn2+ trafficking. Autophagy, 2024 (PubMed: 37876250) [IF=14.6]

Application: WB    Species: human    Sample: NP cells

Figure 4. NLRX1 induces selective mitochondrial fission and mitophagy to maintain adaptive mitochondrial morphology. Primary human NP cells isolated from degenerated NP tissues were prepared. (A) Co-localization analysis of mCherry and GFP in live stable mCherry-GFP-MAP1LC3B-expressing NP cells following the treatments of PBS, TBHP or Baf-A1 with NLRX1 overexpression or not, scale bar: 200 μm. (B and C) protein expressions of mitophagy indicators (MAP1LC3B-II, TOMM20, TIMM23) in primary human NP cells isolated from degenerated NP tissues following the treatments of PBS, TBHP or Baf-A1 with NLRX1 overexpression or not, as determined by western blotting. (D-F) mitochondrial morphology analysis by fluorescence microscope with MitoTracker Red CMXRos label (D and E) and transmission electron microscopy (TEM) (F) in primary human NP cells isolated from degenerated NP tissues following the treatments of PBS or TBHP with NLRX1 overexpression or not, fluorescent scale bar: 5 μm, TEM scale bar: 2 μm (upper panel), 500 nm (lower panel). (G and H) protein expressions of mitochondrial dynamics indicators (p-DNM1L, DNM1L, MFF, MFN1, MFN2, OPA1, OMA1) in primary human NP cells isolated from degenerated NP tissues following the treatments of PBS or TBHP with NLRX1 overexpression or not. (I and J) protein expressions of PINK1 and PRKN in primary human NP cells isolated from degenerated NP tissues following the treatments of PBS or TBHP with NLRX1 overexpression or not. (K) confocal analysis of MitoTracker labeling and PRKN protein with if staining in primary human NP cells isolated from degenerated NP tissues following the treatments of PBS or TBHP with NLRX1 overexpression or not, scale bar: 10 μm. Data are represented as mean ± SD.

2). Macrophage-derived mitochondria-rich extracellular vesicles aggravate bone loss in periodontitis by disrupting the mitochondrial dynamics of BMSCs. Journal of nanobiotechnology, 2025 (PubMed: 40075447) [IF=10.2]

Application: WB    Species: Mouse    Sample: BMSCs

Fig. 5. LCN2 regulates OMA1 and OPA1, thereby disrupting the formation of mitochondrial donuts and osteogenesis. A Volcano plot showing significant DEPs (fold change > 1.5 or

3). Niujiaodihuang Detoxify Decoction Inhibits D-GalN/LPS-induced Hepatocyte Ferroptosis by Maintaining Mitochondrial Homeostasis Via OMA1-OPA1 Pathway. Journal of physiological investigation, 2025 (PubMed: 40908818)

Application: WB    Species: human    Sample: LO2 cells

Figure 7 Niujiaodihuang Detoxify Decoction (NDD) medicated serum improves mitochondrial function via mitochondrial homeostasis regulated by the OMA1-OPA1 pathway in LO2 cells. Western blotting was taken to determine the effect of NDD medicated serum on the expression of OMA1 and L-OPA1 (a); WB detection the interference potency of SiRNA-OPA1 (b); Western blotting was applied to examine the effect of NDD medicated serum on the expression of mitochondrial function-related proteins MFN1, MFN2, and DRP1 (c); The JC-1 kit was used to detect mitochondrial membrane potential (d); Kits were employed to measure reactive oxygen species levels (e). Data were presented as means ± standard error of mean.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.